George Farmer
Stock Analyst at Scotiabank
(2.15)
# 2,815
Out of 4,760 analysts
67
Total ratings
40.54%
Success rate
-2.38%
Average return
Main Sectors:
Top Industries:
Stocks Rated by George Farmer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JANX Janux Therapeutics | Maintains: Sector Perform | $62 → $41 | $30.22 | +35.67% | 4 | Feb 28, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Sector Perform | $78 → $80 | $72.03 | +11.06% | 8 | Feb 20, 2025 | |
| BIIB Biogen | Maintains: Sector Outperform | $244 → $224 | $150.71 | +48.63% | 3 | Feb 13, 2025 | |
| VKTX Viking Therapeutics | Initiates: Sector Outperform | $102 | $27.96 | +264.81% | 1 | Feb 13, 2025 | |
| SAGE Sage Therapeutics | Maintains: Sector Outperform | $14 → $12 | $7.27 | +65.06% | 5 | Feb 12, 2025 | |
| INMB INmune Bio | Maintains: Sector Outperform | $22 → $23 | $7.95 | +189.31% | 2 | Feb 11, 2025 | |
| SNDX Syndax Pharmaceuticals | Maintains: Sector Perform | $18 → $16 | $12.53 | +27.69% | 3 | Jan 8, 2025 | |
| KURA Kura Oncology | Maintains: Sector Perform | $18 → $10 | $7.24 | +38.12% | 2 | Jan 8, 2025 | |
| NAMS NewAmsterdam Pharma Company | Maintains: Sector Outperform | $35 → $47 | $23.37 | +101.11% | 3 | Dec 11, 2024 | |
| ARGX argenx SE | Upgrades: Sector Outperform | $439 → $715 | $571.00 | +25.22% | 5 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $20 → $23 | $7.21 | +219.00% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $20 | $2.54 | +687.40% | 1 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $21 → $41 | $2.51 | +1,536.73% | 3 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $70 → $76 | $34.03 | +123.33% | 4 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $3.15 | $0.45 | +599.84% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $13 | $3.06 | +324.84% | 1 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $13 | $0.79 | +1,549.12% | 2 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $66 | $72.12 | -8.49% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $109 | $35.96 | +203.11% | 3 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $94 → $87 | $71.13 | +22.31% | 5 | Nov 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $2.16 | +1,427.78% | 1 | Oct 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $40 | $1.09 | +3,569.72% | 1 | Jul 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $20 → $27 | $39.16 | -31.04% | 3 | May 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $89 → $75 | $86.69 | -13.48% | 3 | Apr 29, 2020 |
Janux Therapeutics
Feb 28, 2025
Maintains: Sector Perform
Price Target: $62 → $41
Current: $30.22
Upside: +35.67%
BioMarin Pharmaceutical
Feb 20, 2025
Maintains: Sector Perform
Price Target: $78 → $80
Current: $72.03
Upside: +11.06%
Biogen
Feb 13, 2025
Maintains: Sector Outperform
Price Target: $244 → $224
Current: $150.71
Upside: +48.63%
Viking Therapeutics
Feb 13, 2025
Initiates: Sector Outperform
Price Target: $102
Current: $27.96
Upside: +264.81%
Sage Therapeutics
Feb 12, 2025
Maintains: Sector Outperform
Price Target: $14 → $12
Current: $7.27
Upside: +65.06%
INmune Bio
Feb 11, 2025
Maintains: Sector Outperform
Price Target: $22 → $23
Current: $7.95
Upside: +189.31%
Syndax Pharmaceuticals
Jan 8, 2025
Maintains: Sector Perform
Price Target: $18 → $16
Current: $12.53
Upside: +27.69%
Kura Oncology
Jan 8, 2025
Maintains: Sector Perform
Price Target: $18 → $10
Current: $7.24
Upside: +38.12%
NewAmsterdam Pharma Company
Dec 11, 2024
Maintains: Sector Outperform
Price Target: $35 → $47
Current: $23.37
Upside: +101.11%
argenx SE
Nov 5, 2024
Upgrades: Sector Outperform
Price Target: $439 → $715
Current: $571.00
Upside: +25.22%
Oct 18, 2024
Maintains: Sector Outperform
Price Target: $20 → $23
Current: $7.21
Upside: +219.00%
Sep 30, 2024
Initiates: Sector Outperform
Price Target: $20
Current: $2.54
Upside: +687.40%
Sep 27, 2024
Maintains: Sector Outperform
Price Target: $21 → $41
Current: $2.51
Upside: +1,536.73%
Aug 12, 2024
Maintains: Sector Outperform
Price Target: $70 → $76
Current: $34.03
Upside: +123.33%
May 30, 2024
Initiates: Sector Outperform
Price Target: $3.15
Current: $0.45
Upside: +599.84%
Mar 14, 2024
Initiates: Sector Outperform
Price Target: $13
Current: $3.06
Upside: +324.84%
Mar 14, 2024
Initiates: Sector Outperform
Price Target: $13
Current: $0.79
Upside: +1,549.12%
Dec 19, 2023
Initiates: Sector Outperform
Price Target: $66
Current: $72.12
Upside: -8.49%
Nov 17, 2020
Downgrades: Market Perform
Price Target: $109
Current: $35.96
Upside: +203.11%
Nov 6, 2020
Maintains: Market Perform
Price Target: $94 → $87
Current: $71.13
Upside: +22.31%
Oct 27, 2020
Initiates: Outperform
Price Target: $33
Current: $2.16
Upside: +1,427.78%
Jul 20, 2020
Initiates: Outperform
Price Target: $40
Current: $1.09
Upside: +3,569.72%
May 6, 2020
Maintains: Market Perform
Price Target: $20 → $27
Current: $39.16
Upside: -31.04%
Apr 29, 2020
Maintains: Outperform
Price Target: $89 → $75
Current: $86.69
Upside: -13.48%